Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PedPRM in Children and Adolescents With Impaired Sleep and Anorexia Nervosa
NCT07576764Phase 3Not yet recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Sep 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in sleep disorder, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Total Sleep Time. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT07576764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07576764.